FLR
52
3
CTAS
39
3
FE
52
-8
XYL
33
2
D
25
-3
UHS
64
4
CI
69
11
CSCO
60
3
ZION
67
3
SYK
44
4
DNB
62
12
GOOG
61
6
HSIC
57
3
PPG
44
3
HD
44
4
APD
44
2
VMC
68
3
FITB
62
3
THC
61
6
KIM
64
6
FLR
52
3
CTAS
39
3
FE
52
-8
XYL
33
2
D
25
-3
UHS
64
4
CI
69
11
CSCO
60
3
ZION
67
3
SYK
44
4
DNB
62
12
GOOG
61
6
HSIC
57
3
PPG
44
3
HD
44
4
APD
44
2
VMC
68
3
FITB
62
3
THC
61
6
KIM
64
6
Financhill
Back

EyePoint Pharmaceuticals Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
33

EYPT
EyePoint Pharmaceuticals

Last Price:
$6.23
Seasonality Move:
16.96%
Buy
52

SRPT
Sarepta Therapeutics

Last Price:
$73.63
Seasonality Move:
14.66%
Sell
33
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $6.34. The Score for EYPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $76.33. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $6.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $76.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 45.37 Sell
Chaikin Money Flow: -580139 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6 - 6.88) Sell
Bollinger Bands (100): (6.36 - 9.76) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.07 Sell
Relative Strength Index (14 RSI): 30.8 Sell
Chaikin Money Flow: 1304026 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.54 - 110.54) Sell
Bollinger Bands (100): (102.23 - 127.85) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.38 Sell
20-day SMA: 6.48 Sell
50-day SMA: 6.94 Sell
200-day SMA: 8.5 Sell
8-day EMA: 6.39 Sell
20-day EMA: 6.52 Sell
50-day EMA: 6.95 Sell
200-day EMA: 9.12 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.29 Sell
20-day SMA: 96.26 Sell
50-day SMA: 107.61 Sell
200-day SMA: 124.92 Sell
8-day EMA: 82.75 Sell
20-day EMA: 92.99 Sell
50-day EMA: 104.03 Sell
200-day EMA: 117.97 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):